A REVIEW ON POLOXAMER AND HYDROXY PROPYL METHYL CELLULOSE COMBINATION AS THERMORESPONSIVE POLYMERS IN NOVEL OPHTHALMIC IN SITU GEL FORMULATION AND THEIR CHARACTERIZATION
Poor bioavailability is one of the most significant problem in the delivery of the ocular drug system. Ophtalmic ointments, solutions and suspensions are the most frequently used dosage forms to treat ocular disease, and their effectiveness as a drug are compromised by several limitations that lead to poor ocular bioavailability. In situ gel is one of the most promising strategy and solution to improve the ocular bioavailability of drugs. The purpose of this review is to discuss the formulation and characterization of in situ gel. This review is written based on the data or information obtained by using several search engines and several scientific journals, focused on Poloxamer 407 and Hydroxy Propyl Methyl Cellulose (HPMC) bases combination.
2. MA Fathalla, Z, Vangala A, Longman M, Khaled KA, Hussein AK, ElGarhy OH, Alany RG. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. Eur J Pharm Biopharm 2017;114:119-34.
3. Jethava JK and Jethava GK. Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine. Int J Pharm Investig 2014;4(4);226-32.
4. Kumar D, Jain N, Gulati N, Nagaich U. Nanoparticles laden in situ gelling system for ocular drug targeting. J Adv Pharm Technol Res 2013;4(1):9-17.
5. Agarwal K, Mehta N, Namdev A, Gupta A. In-Situ Gel Formation for Ocular Drug Delivery System an Overview. Asian J Biomed Pharm Sci 2011;1(4):01-07.
6. Lou J, Hu W, Tian R, Zhang H, Jia Y, Zhang J, Zhang L. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomedicine 2014;9:2517-25.
7. Rajoria G and Gupta A. In-situ Gelling System: A Novel Approach for Ocular Drug Delivery. Am J PharmTech Res 2012;2(4):24-53.
8. Kotreka UK, Davis VL, Adeyeye MC. Development of topical ophthalmic In situ gelforming estradiol delivery system intended for the prevention of age-related cataracts. PLOS ONE 2017; 12(2):1-19.
9. El Laithy H, Nesseem D, Shoukry M. Evaluation of two in situ gelling systems for ocular delivery of Moxifloxacin: In vitro and in vivo studies. J Chem Pharm Res 2011;3(2):66-79.
10. Lin HR, Sung KC. Carbopol/Pluronic phase change solutions for ophthalmic drug delivery. J Control Release 2000;69:379-88.
11. Pawar P, Kashyap H, Malhotra S, Rakesh S. Hp-?-CD-Voriconazole In situ Gelling System for Ocular Drug Delivery: In Vitro, Stability, and Antifungal Activities Assessment. BiomedResearch International 2013:1-9.
12. Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh SYK, Kim CK. Development of In situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm 1998;165(1):33-44.
13. Chand P, Pratibha, Gnnarajan G, Kothiyal. In situ gel: A Review. Indian J Pharm Biol Res 2016;4(2):11-9.
14. Aishwarya JJ, Sheetal BG, Ravindra BS. A Review on nasal drug delivery system. World Journal of Pharmacy and Pharmaceutical Sciences 2014;3(8):231-54.
15. Prajapati N and Goyal A. A Review: Thermoreversible Mucoadhesive In- Situ Gel. International Journal of Innovative Drug Discovery 2013;3(2):67-84.
16. Saini R, Saini S, Singh G, Banerjee A. In Situ Gels - A New Trends In Ophthalmic Drug Delivery Systems. Int J Pharm Sci Res 2015;6(05):886-90.
17. Parekh HB, Rishad J, Jivani NP, Patel LD, Makwana A, Sameja K. Novel In situ Polymeric Drug Delivery System: A Review. J Drug Deliv Therap 2012;2(5):136-45.
18. Nirmal HB, Bakliwal SR, Pawar SP. In situ Gel: New Trends in Controlled and Sustained Drug Delivery System. Int J Pharm Tech Res 2010;2(2):1398-408.
19. Nerkar TS, Gujarathi NA, Bhushan R, Bakliwal SR, Pawar SP. In situ Gel: Novel Approach in Sustained and Controlled Drug Delivery System. Pharma Sci Monitor 2013; 4(4):1-18.
20. Laddha UD and Mahajan HS. An insight to ocular in situ gelling systems. International Journal of Advances in Pharmaceutics 2017;06(02):31-40.
21. Rathore KS. In situ gelling ophthalmic drug delivery system: an overview. Int J Pharm Sci Res 2010;2:30-4.
22. Cao Y, Zhang C, Shen W et al. Poly (N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Rel 2007; 120:186-94.
23. Kute PR, Gondkar SB, Saudagar RB. Ophthalmic in-situ gel: an overview. World J Pharm Pharma Sci 2015;4(4):549-68.
24. Israr S, Nesalin J, Mani TT. A novel approach of ophthalmic drug delivery: in situ gel. J Pharm Res 2015;4(3):121-24.
25. Makwana SB, Patel VA, Parmar SJ. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results Pharma Sci 2016;6: 1-6.
26. Gowda DV, Tanuja D, Khan MS, Desai J, Shivakumar HG. Formulation and evaluation of in-situ gel of diltiazem hydrochloride for nasal delivery. Pharm Lett 2011;3(1):371-81.
27. Geethalakshmi A, Karki R, Jha SK, Venkatesh DP, Nikunj B. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system. Curr Drug Deliv 2012;9(2):197-204.
28. Wee S, Gombotz WR. Protein release from alginate matrices. Adv Drug Deliv Rev 1998;31(3):267-85.
29. Champalal KD and Sushilkumar P. Current Status of Ophthalmic In situ Forming Hydrogel. Int J Pharm Bio Sci 2012;3(3):372-88.
30. Nanjawade. In situ forming hydrogels for sustained ophthalmic drug delivery. Journal of Controlled Release 2007;122: 119-34.
31. Nagaich U, Jain N, Kumar D, Gulati N. Controlled ocular drug delivery of ofloxacin using temperature modulated in situ gelling system. Journal of the Scientific Society 2013;40(2):90-4.
32. Ali Khatera NA, Soliman OA, Mohamed EA. In Situ Gelling Ophthalmic Formulations for Sustained Release and Enhanced Ocular Delivery of Fluconazole. IOSR Journal of Pharmacy and Biological Sciences 2016;11(2):43-51.
This work is licensed under a Creative Commons Attribution 4.0 International License.